.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Find suppliers and generic API sources

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Covington
Farmers Insurance
Express Scripts
Colorcon
Fish and Richardson
Queensland Health
Baxter
Argus Health
Johnson and Johnson

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205919

« Back to Dashboard
NDA 205919 describes PURIXAN, which is a drug marketed by Nova Labs Ltd and is included in one NDA. It is available from one supplier. Additional details are available on the PURIXAN profile page.

The generic ingredient in PURIXAN is mercaptopurine. There are ten drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mercaptopurine profile page.

Summary for NDA: 205919

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details

Pharmacology for NDA: 205919

Suppliers and Packaging for NDA: 205919

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PURIXAN
mercaptopurine
SUSPENSION;ORAL 205919 NDA Nova Laboratories, Ltd 62484-0020 62484-0020-2 1 BOTTLE in 1 CARTON (62484-0020-2) > 100 mL in 1 BOTTLE (62484-0020-1)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength20MG/ML
Approval Date:Apr 28, 2014TE:RLD:Yes
Regulatory Exclusivity Expiration:Apr 28, 2021
Regulatory Exclusivity Use:ORPHAN DRUG EXCLUSIVITY


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Dow
US Army
Medtronic
Daiichi Sankyo
Fish and Richardson
Fuji
Colorcon
Cantor Fitzgerald
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot